Belimumab - Lupus nephritis
You are here : Home > Formulary Search > Belimumab - Lupus nephritis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Belimumab
Indication :
Lupus nephritis
Group Name :
Keywords :
Brand Names Include :
Benlysta
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Belimumab is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Lupus nephritis.
- No records returned.
Committee Recommendations (1)
This drug has not yet been assessed for formulary status.
It has not yet been evaluated by NICE or the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.